Veraxa Biotech Holding AG (VRXA) Total Debt (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted Total Debt of $3.6 million for Q4 2025, up 51.32% on a QoQ basis from $2.4 million in Q4 2024, and up 51.32% YoY from $2.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Total Debt (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Total Debt for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Total Debt rose 51.32% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 51.32% YoY), and the FY2025 full-year result was $3.6 million, up 51.32% from the prior year.
- Total Debt climbed to $3.6 million in Q4 2025 per VRXA's latest filing, from $2.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $3.6 million in Q4 2025 to a low of $2.4 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 2.40 Mn |